Biotech Bull Market: Trends to Watch in 2015… #3
Biotech Sector Moves Up In Tiny Steps Risk Remains On AACR Next Week Will Move Cancer Stocks Biotech indices and ETFs are trying to hit new highs but momentum is easing and trading is choppy. Nonetheless we are moving up from the brief correction near channel lows at the end of Q1. Sentiment...
Risk Back On:Biotech Stocks Rally- IBB, XBI… Update-1…CLVS
4/13 Update Biotech Sector Uptrend Intact XBI at 232.09 Clovis Oncology (CLVS) Up 13% On Upgrade Biotech Sector Brings In Buyers The late Q1 sell-off appears over as buyers are coming in near the 5o day moving average of the XBI, the more volatile ETF.The IBB shows a similar chart and both are...
Ignyta: Precision Medicine for Oncology Integrating Companion Diagnostics
Teva Deal Expands Portfolio and Diagnostic Capabilities Adding RXDX to Rayno Small Cap Portfolio Ignyta, Inc. (RXDX) is an emerging biopharmaceutical Company targeting new oncology drugs that inhibit Tyrosine kinase receptors (Trk) with integrated biomarker-based companion diagnostics for each...
Sierra SnowBlog: A Little Relief Next Week 4/5, Drought… Update-1 4/7
Update -2 The Coot Indicator Look for coots (crane relative) on Little Lake at US 395 South of Lone Pine. Two weeks ago during a warming trend the coots were still there indicating winter was still on. The coots head out of the Eastern Sierras in the Spring. This a Winter Storm arrived. The...
Risk-Off for Biotech Trades… Update-2
4/1...at close ETF summary FBT at $116.87 down 1.15%, early support at $115. IBB at $340 touching bottom of upward channel, down 1%. XBI at $220.50 down 2.22%. At technical support. ETF leader with equal weight holdings in small and mid-caps. Another weak day for large caps ALXN, AMGN, BIIB,...